C
Cyclacel Pharmaceuticals
CYCC
1.66000
USD
0.02
(1.22%)
مفتوح الان
حجم التداول
930,624
الربح لكل سهم
0
العائد الربحي
0
P/E
-0
حجم السوق
2,803,370
الأخبار
العنوان: Cyclacel Pharmaceuticals
القطاع: Healthcare
الصناعة: Biotechnology
Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors, and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib, Sapacitabine, and plogosertib.